Thelma Therapeutics (XKRX:015540) Total Liabilities : ₩16,435 Mil (As of Sep. 2022)

View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Total Liabilities?

Thelma Therapeutics's Total Liabilities for the quarter that ended in Sep. 2022 was ₩16,435 Mil.

Thelma Therapeutics's quarterly Total Liabilities increased from Mar. 2022 (₩13,806.27 Mil) to Jun. 2022 (₩15,682.33 Mil) and increased from Jun. 2022 (₩15,682.33 Mil) to Sep. 2022 (₩16,434.74 Mil).

Thelma Therapeutics's annual Total Liabilities increased from Dec. 2019 (₩12,785.58 Mil) to Dec. 2020 (₩31,789.90 Mil) but then declined from Dec. 2020 (₩31,789.90 Mil) to Dec. 2021 (₩13,025.88 Mil).

Thelma Therapeutics Total Liabilities Historical Data

The historical data trend for Thelma Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Total Liabilities Chart

Thelma Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Liabilities

Get a 7-Day Free Trial

9,916.68

15,945.34

12,785.58

31,789.90

13,025.88

Thelma Therapeutics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Liabilities	Get a 7-Day Free Trial															29,693.79	13,025.88	13,806.27	15,682.33	16,434.74

Thelma Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Thelma Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12800.113	+	(26.542	+	-1.7053025658242E-13
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	199.225)
	=	13,026

Total Liabilities	=	Total Assets (A: Dec. 2021 )	-	Total Equity (A: Dec. 2021 )
	=	27882.145	-	14856.265
	=	13,026

Thelma Therapeutics's Total Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16254.675	+	(0	+	38.114999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	141.954)
	=	16,435

Total Liabilities	=	Total Assets (Q: Sep. 2022 )	-	Total Equity (Q: Sep. 2022 )
	=	26969.867	-	10535.123
	=	16,435

Thelma Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Thelma Therapeutics (XKRX:015540) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR

Website

http://www.medi-plant.co.kr

Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines